Associated Papers
A novel somatic CALR mutation in essential thrombocythemia and effective response to interferon-alfa-2b therapy.
Zhang X et al.
Blood Cells, Molecules & Diseases, 2018
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.
Lim KH et al.
Oncotarget, 2017
Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2016
Select a paper to view details